Increased levels of high sensitive Troponin-T after first dose of Adriamycin containing therapy may predict brain-type natriuretic rise after 6 months in patients with breast carcinoma
Scientific Reports in Medicine · 26.04.2026 · 3 (1) · 12-22
DOI: 10.37609/srinmed.67 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports in Medicine, online erschienen am 26.04.2026. Verfasst von Osman Şahin und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
In this study, we aimed to investigate the usefulness of highly sensitive troponin-T (hs-TnT) levels for the early prediction of anthracycline-related cardiac stress and subclinical cardiac dysfunction.
Method
Patients newly diagnosed with breast cancer with normal cardiac function were randomized to our study. All patients had taken 240 mg/m2 adriamycin in 12 weeks. Brain-type natriuretic peptide (BNP) and hs-TnT levels were measured; echocardiography and tissue Doppler imaging was performed to all patients for 4 times: at baseline, 4-12 hours after first adriamycin dose, at 3 months and at 6 months.
Results
A total of 43 women (52.7±12.1 years) with breast cancer were included in our study. Brain natriuretic peptide elevation was observed in 8 patients, in which 2 of them showed symptoms and signs of overt heart failure. In the logistic regression analysis, hs-TnT levels (OR: 1.154; (0.974–1.336 in 95% CI) and BNP levels (OR: 1.009 (1.001-1.018 in 95 % CI) measured 12–24 hours after first adriamycin dose were independently associated with BNP rise at 6th month. Receiver operating curve analysis revealed a cut-off value of 12.85 ng/L for hs-TnT levels to predict BNP elevation at 6th month with 62.5% sensitivity and 85.7% specificity.Conclusion: hs-TnT levels after first dose of adriamycin containing therapy higher than 18.65 ng/L was associated with BNP elevation at 6th month with a specificity of 97.1% in our patient group. Early hs-TnT elevation may represent a potential marker of chemotherapy-related cardiac dysfunction.
Zitieren
APA
Şahin, O., Çağlayan, Ç. E., Celik, A. İ., Matyar, S., Cureoglu, A., Karaaslan, M. B., Demirtas, M., & Paydas, S. (2026). Increased levels of high sensitive Troponin-T after first dose of Adriamycin containing therapy may predict brain-type natriuretic rise after 6 months in patients with breast carcinoma. Scientific Reports in Medicine, 3(1), 12-22. https://doi.org/10.37609/srinmed.67
Vancouver
Şahin O, Çağlayan ÇE, Celik Aİ, Matyar S, Cureoglu A, Karaaslan MB, et al. Increased levels of high sensitive Troponin-T after first dose of Adriamycin containing therapy may predict brain-type natriuretic rise after 6 months in patients with breast carcinoma. Scientific Reports in Medicine. 2026;3(1):12-22. doi:10.37609/srinmed.67
BibTeX
@article{ahin2026,
author = {Şahin, Osman and Çağlayan, Çağlar Emre and Celik, Aziz İnan and Matyar, Selcuk and Cureoglu, Asligul and Karaaslan, Muhammet Buğra and Demirtas, Mustafa and Paydas, Semra},
title = {Increased levels of high sensitive Troponin-T after first dose of Adriamycin containing therapy may predict brain-type natriuretic rise after 6 months in patients with breast carcinoma},
journal = {Scientific Reports in Medicine},
year = {2026},
volume = {3},
number = {1},
pages = {12--22},
doi = {10.37609/srinmed.67}
}
EUVIMED